Targeting the F1Fo ATP synthase: Modulation of the body's powerhouse and its implications for human disease

Current Medicinal Chemistry

Volumn 18, Issue 30, 2011, Pages 4684-4714

  Johnson, John A ^a   Ogbi, Mourad ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Disease; F1F1 ATP synthase; Kinases; Mitochondria; Oxidative phosphorylation; Subunits

Indexed keywords

1,1,1 TRICHLORO 2 (2 CHLOROPHENYL) 2 (4 CHLOROPHENYL)ETHANE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ADENOSINE TRIPHOSPHATE; ALMITRINE; ANGIOSTATIN; ATRAZINE; BISMUTH CITRATE; CHAPERONE; CIGARETTE SMOKE; CYCLOPHILIN D; CYCLOSPORIN A; DEXAMETHASONE; ESTRADIOL; FLUTAMIDE; GALECTIN 3; GENISTEIN; HYDROGEN PEROXIDE; INHIBITOR PROTEIN; METHYLMERCURY; MITOCHONDRIAL DNA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NEU DIFFERENTIATION FACTOR; OLIGOMYCIN; PHENYLEPHRINE; PLATELET DERIVED GROWTH FACTOR; POLYCHLORINATED BIPHENYL; PROPRANOLOL; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RESVERATROL; UNINDEXED DRUG; ADENINE NUCLEOTIDE TRANSLOCASE; CORTICOSTEROID;

AGING; ALBINISM; ALCOHOLISM; ALZHEIMER DISEASE; APOPTOSIS; AUTOIMMUNITY; BRAIN DISEASE; CALORIC RESTRICTION; CARDIOMYOPATHY; COUPLING FACTOR; CYTOSOL; DIABETES MELLITUS; DIET RESTRICTION; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME ELECTROPHORESIS; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME STRUCTURE, FUNCTION AND VARIABILITY; ENZYME SUBUNIT; GINKGO BILOBA; HEART CYCLE; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HELICOBACTER INFECTION; HUMAN; HYDROLYSIS; HYPERTENSION; IMMUNE DEFICIENCY; LEIGH DISEASE; MELAS SYNDROME; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MODULATION; NARP SYNDROME; NEOPLASM; NONHUMAN; PARKINSONISM; PLACENTA INSUFFICIENCY; PROTEIN HOMEOSTASIS; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REPERFUSION INJURY; REVIEW; ANIMAL; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN SUBUNIT;

ADENOSINE TRIPHOSPHATE; ADRENAL CORTEX HORMONES; AGING; ALBINISM; ALCOHOLISM; ANIMALS; AUTOIMMUNE DISEASES; BACTERIAL INFECTIONS; CALORIC RESTRICTION; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MITOCHONDRIAL ADP, ATP TRANSLOCASES; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MODELS, MOLECULAR; NEOPLASMS; OXIDATIVE PHOSPHORYLATION; PROTEIN SUBUNITS;

EID: 80053484553     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: None     Document Type: Review

References (303)

1. Kalckar, H.M. 50 years of biological research - from oxidativephosphorylation to energy-requiring transport regulation. Annu. Rev.Biochem., 1991, 60, 1-37.
2. Penefsky, H.S.; Myanard, E.P.; Anima, D.; Racker E. Partial resolution ofthe enzymes catalyzing oxidative phosphorylation:II. Participation of asoluble adenosine triphosphatase in oxidative phosphorylation. J. Biol. Chem., 1960, 235, 3330-3336.
3. Kagawa, Y.; Racker, E. Partial resolution of the enzymes catalyzingoxidative phophorylation: IX. Reconstruction of oligomycin- sensitiveadenosine triphosphatase. J. Biol. Chem., 1966, 241, 2467-2474.
4. Mitchell, P. Coupling of phosphorylation to electron and hydrogen transferby a chemi-osmotic type of mechanism. Nature, 1961, 191, 144-148.
5. Boyer, P.D.; Cross, R.L.; Momsen, W. A new concept for energy coupling inoxidative phosphorylation based on a molecular explanation of the oxygenexchange reactions. Proc. Natl. Acad. Sci. U.S.A., 1973, 70, 2837-2839.
6. Boyer, P.D.; Stokes, B.O.; Wolcott, R.G.; Degani, C. Coupling of highenergy phosphate bonds to energy transductions. Fed. Proc., 1975, 34, 1711-1717.
7. Boyer, P.D.; Chance, B.; Ernster, L.; Mitchell, P.; Racker, E.; Slater, E.C.Oxidative phosphorylation and photophosphorylation. Annu. Rev. Biochem. , 1977, 46, 955-966.
8. Rosing, J.; Kayalar, C.; Boyer, P.D. Evidence for energy-dependent changein phosphate binding for mitochondrial oxidative phosphorylation based onmeasurements of medium and intermediate phosphate-water exchanges. J. Biol. Chem., 1977, 252, 2478-2485. (Pubitemid 8094193)
9. Kayalar, C.; Rosing, J.; Boyer, P.D. An alternating site sequence foroxidative phosphorylation suggested by measurement of substrate bindingpatterns and exchange reaction inhibitions. J. Biol. Chem., 1977, 252, 2486-2491. (Pubitemid 8094194)
10. Walker, J.E.; Cozens, A.L.; Dyer, M.R.; Fearnley, I.M.; Powell, S.J.;Runswick, M.J. Structure and genes of ATP synthase. Biochem. Soc. Trans., 1987, 15, 104-106. (Pubitemid 17010271)
11. Walker, J.E.; Lutter, R.; Dupuis, A.; Runswick, M.J. Identification of thesubunits of F1Fo-ATPase from bovine heart mitochondria. Biochemistry, 1991, 30, 5369-5378.
12. Collinson, I.R.; Runswick, M.J.; Buchanan, S.K.; Fearnley, I.M.; Skehel, J.M.; van Raaij, M.J.; Griffiths, D.E.; Walker, J.E. Fo membrane domain ofATP synthase from bovine heart mitochondria: purification, subunitcomposition, and reconstitution with F1-ATPase. Biochemistry, 1994, 33, 7971-7978.
13. Abrahams, J.P.; Leslie, A.G.; Lutter, R.; Walker, J.E. Structure at 2.8 Aresolution of F1-ATPase from bovine heart mitochondria. Nature, 1994, 370(6491), 621-628.
14. Walker, J.E. The regulation of catalysis in ATP synthase. Curr. Opin. Struct.Biol., 1994, 4, 912-918.
15. Noji, H.; Yasuda, R.; Yoshida, M.; Kinosita, K. Jr. Direct observation of therotation of F1-ATPase. Nature, 1997, 386, 299-302.
16. Capaldi, R.A.; Aggeler, R. Mechanism of the F(1)F(0)-type ATP synthase, abiological rotary motor. Trends. Biochem. Sci., 2002, 27, 154-160. (Pubitemid 34219326)
17. von Ballmoos, C.; Wiedenmann, A.; Dimroth, P. Essentials for ATPsynthesis by F1Fo ATP synthases. Annu. Rev. Biochem., 2009, 78, 649-672.
18. Borsch, M.; Diez, M.; Zimmermann, B.; Reuter, R.; Gräber, P. Stepwiserotation of the gamma-subunit of EF(0)F(1)-ATP synthase observed byintramolecular single-molecule fluorescence resonance energy transfer.FEBS Lett., 2002, 527, 147-152. (Pubitemid 35253856)
19. Adachi, K.; Oiwa, K.; Nishazaka, T.; Furuike, S.; Noji, H.; Itoh, H.; Yoshida, M.; Kinoshita, K., Jr. Coupling of rotation and catalysis in F1-ATPaserevealed by single-molecule imaging and manipulation. Cell, 2007, 130, 309-321. (Pubitemid 47086326)
20. Meyer, B.; Wittig, I.; Trifilieff, E.; Karas, M; Schägger, H. Identification oftwo proteins associated with mammalian ATP synthase. Mol. Cell.Proteomics, 2007, 6, 1690-1699. (Pubitemid 350031671)
21. Gibbons, C.; Montgomery, M.G.; Leslie, A.G.; Walker, J.E. The structure ofthe central stalk in bovine F(1)-ATPase at 2.4 A resolution. Nat. Struct. Biol., 2000, 11, 1055-1061.
22. Karrasch, S.; Walker, J.E. Novel features in the structure of bovine ATPsynthase. J. Mol. Biol., 1999, 290, 379-384. (Pubitemid 29324824)
23. Rubinstein, J.L.; Walker, J.E.; Henderson, R. Structure of the mitochondrialATP synthase by electron cryomicroscopy. EMBO J., 2003, 22, 6182-6192. (Pubitemid 37522576)
24. Cabezon, E.; Montgomery, M.G.; Leslie, A.G.; Walker, J.E. The structure ofbovine F1-ATPase in complex with its regulatory protein IF1. Nature Struct.Biol., 2003, 10, 744-750. (Pubitemid 37052414)
25. Bason, J.V.; Runswick, M.J.; Fearney, I.M.; Walker, J.E. Binding of theinhibitor protein IF1 to bovine F1-ATPase. J. Mol. Biol., 2011, 406, 443-453.
26. Zheng, J.; Ramirez, V.D. Purification and identification of an estrogenbinding protein from rat brain: oligomycin sensitivity-conferring protein(OSCP), a subunit of mitochondrial F0F1-ATP synthase/ATPase. J. SteroidBiochem. Mo.l Biol., 1999, 68, 65-75. (Pubitemid 29130387)
27. Walker, J.E.; Dicksen, V.K. The peripheral stalk of the mitochondrial ATPsynthase. Biochim. Biophys. Acta, 2006, 1757, 286-296.
28. Nguyen, T.; Ogbi, M.; Johnson, J.A. Delta protein kinase C interacts with the"d" subunit of the F1Fo ATPase in neonatal cardiac myocytes exposed tohypoxia or phorbol ester: Implications for F1Fo ATPase regulation. J. Biol. Chem., 2008, 283, 29831-29840.
29. Nguyen, T.; Ogbi, M.; Yu, Q.; Johnson, J.A. Attenuation of the hypoxiainducedprotein kinase C interaction with the "d" subunit of F1Fo ATPsynthase in neonatal cardiac myocytes: implications for energy preservationand survival. Biochem. J., 2010, 429, 335-345.
30. Giorgio, V.; Bisetto, E.; Soriano, M.E.; Dabbeni-Sala, F.; Basso, E.;Petronilli, V.; Forte, M.A.; Bernardi, P.; Lippe, G. Cyclophilin D modulatesmitochondrial F0F1-ATP synthase by interacting with the lateral stalk of thecomplex. J. Biol. Chem., 2009, 284, 33982-33988.
31. Belogradov, G.I. Recent advances in structure-functional studies ofmitochondrial factor B. J. Bioenerg. Biomembr., 2009, 41, 137-143.
32. Tsunoda, S.P.; Aggeler, R.; Yoshida, M.; Capaldi, R. Rotation of the csubunit oligomer in fully functional F1Fo ATP synthase. Proc. Natl. Acad.Sci., USA, 2000, 98, 898-902. (Pubitemid 32121159)
33. Carbajo, R.J.; Kellas, F.A.; Runswick, M.J.; Montgomery, M.G.; Walker, J.E.; Neuhaus, D. Structure of the F1 binding domain of the stator of bovineF1Fo ATPase and how it binds an subunit. J. Mol. Biol., 2005, 351, 824-838. (Pubitemid 41111899)
34. Rees, D.M.; Leslie, A.G.W.; Walker, J.E. The structure of the membraneextrinsic region of bovine ATP synthase. Proc. Natl. Acad. Sci., USA, 2009, 106, 21597-215601.
35. Gaballo, A.; Zanotti, F.; Papa, S. Structures and interactions of proteinsinvolved in the coupling function of the protonmotive FoF1 ATP synthase.Curr. Protein Pept. Sci., 2002, 3, 451-460. (Pubitemid 34778187)
36. Junge, W.; Lill, H.; Engelbrecht, S. ATP synthase: an electrochemicaltransducer with rotary mechanics. Trends Biochem. Sci., 1997, 22, 420-423. (Pubitemid 27508785)
37. Vik, S.B.; Antonio, B.J. A mechanism of proton translocation by F1Fo ATPsynthases suggested by double mutants of the a subunit. J. Biol. Chem., 1994, 269, 30364-30369. (Pubitemid 24376512)
38. Boyer, P.D. The binding change mechanism for ATP synthase - someprobabilities and possibilities. Biochim. Biophys. Acta, 2003, 1140, 215-220.
39. Okuno, D.; Lino, R.; Noji, H. Rotation and structure of FoF1-ATP synthase.J. Biochem., 2011, 149, 655-664.
40. Tomashek, J.J.; Brusilow, W.S.A. Stoichiometry of energy coupling byproton-translocating ATPases: A history of variability. J. Bioenerg. & Biomembr., 2000, 32, 493-500. (Pubitemid 32204247)
41. Schemidt, R.A; Qu, J.; Williams, J.R.; Brusilow, W.S.A. Effects of carbonsource on expression of Fo genes and on the stoichiometry of the c subunit inthe F1Fo ATPase of Eschericia coli, J. Bacteriol., 1998, 180, 3205-3208. (Pubitemid 28285036)
42. Chinopoulos, C.; Gerencser, A.A.; Mandi, M.; Mathe, K.; Torocsik, B.;Doczi, J.; Turiak, L.; Kiss, G.; Konrad, C.; Vajda, S.; Vereczki, V.; Oh, R.J.;Adam-Vizi, V. Forward operation of adenine nucleotide translocase duringF0F1-ATPase reversal: critical role of matrix substrate- levelphosphorylation. FASEB J., 2010, 24, 2405-2416.
43. Chinopoulous, C. Mitochondrial consumption of cytosolic ATP: Not so fast.FEBS Lett., 2011, 585, 1255-1259.
44. Mnatsakanyan, N.; Krishnakumar, A. M.; Suzuki, T.; Weber, J. The Role ofthe -DELSEED-loop of ATP Synthase. J. Biol. Chem., 2009, 284, 11336-11345.
45. Wittig, I.; Schägger, H. Structural organization of mitochondrial ATPsynthase. Biochim Biophys Acta., 2008, 1777, 592-598.
46. Murphy, E.; Steenbergen, C. Mechanisms underlying acute protection fromcardiac ischemia-reperfusion injury. Physiol. Rev., 2008, 88, 581-609. (Pubitemid 351520088)
47. Solaini, G.; Harris, D.A. Biochemical dysfunction in heart mitochondriaexposed to ischaemia and reperfusion. Biochem. J., 2005, 390, 377-394. (Pubitemid 41337100)
48. Ingwall, J.S. Whole-organ enzymology of the creatine kinase system in heart.Biochem. Soc. Trans., 1991, 19, 1006-1010.
49. Beharry, S.; Brags, P.D. Properties of bound inorganic phosphate on bovinemitochondrial F1Fo ATP synthase. J. Bioenerg. & Biomembr., 2001, 33, 35-42. (Pubitemid 32294790)
50. Moyle, J.; Mitchell, P. Active / inactive state transitions of mitochondrialATPase molecules influenced by Mg 2+ anions and aurovertin. FEBS Lett., 1975, 56, 55-61.
51. Dunschede, F.; Zwicker, K.; Ackermann, H.; Zimmer, G. ADP- andoligomycin-sensitive redox behavior of Fo b thiol in ATP synthase dependson neighbored primary structure: investigations using 14-C labeled alphalipoic acid. Biofactors, 2003, 19, 19-32. (Pubitemid 38073141)
52. Fernandez-Vizarra, E.; Tiranti, V.; Zeviani, M. Assembly of the oxidativephosphorylation system in humans: What we have learned by studyingdefects. Biochim. Biophys. Acta, 2009, 1793, 200-211.
53. Pícková, A.; Potock ý, M.; Houštěk, J. Assembly factors of F1Fo-ATPsynthase across genomes. Proteins: Structure, Function, and Bioinformatics, 2005, 59, 393-402. (Pubitemid 40594286)
54. Cízková, A.; Stráneck, V.; Mayr, J.A.; Tesarová, M.; Havlícková, V.; Paul, J.; Ivánek, R.; Kuss, A.W.; Hansíková, H.; Kaplanová, V.; Vrback, M.;Hartmannová, H.; Nosková, L.; Honzík, T.; Drahota, Z.; Magner, M.;Hejzlarová, K.; Sperl, W.; Zeman, J.; Houstek, J.; Kmoch, S. TMEM70mutations cause isolated ATP synthase deficiency and neonatalmitochondrial encephalocardiomyopathy. Nature Genetics, 2008, 40, 1288-1290.
55. Tahara, E.B.; Navarere, F.D.; Kowaltowski, A.J. Tissue-, substrate- and sitespecificcharacteristics of mitochon-drial reactive oxygen species generation.Free Radic. Biol. Med., 2009, 46, 1283-1297.
56. Hung, W.Y.; Wu, C.W.; Yin, P.H.; Chang, C.J.; Li, A.F.; Chi, C.W.; Wei, Y.H.; Lee, H.C. Somatic mutations in mitochondrial genome and theirpotential roles in the progression of human gastric cancer. Biochim. Biophys.Acta, 2010, 1800, 264-270.
57. Chevillotte, E.; Giralt, M.; Miroux, B.; Ricquier, D.; Villarroya, F.Uncoupling protein-2 controls adiponectin gene expression in adipose tissuethrough the modulation of reactive oxygen species production. Diabetes, 2007, 56, 1042-1050. (Pubitemid 46525055)
58. Devarajan, A.; Bourguard, N.; Hama, S.; Navab, M.; Grijalva, V.R.;Morvardi, S.; Clarke, C.F.; Vergnes, L.; Reue, K.; Teiber, J.F.; Reddy, S.T.Paroxonase 2 deficiency alters mitochondrial function and exacerbates thedevelop-ment of atherosclerosis. Antioxid. Redox Signal., 2011, 14, 341-351.
59. Liu, Y.; Schubert, D.R. The specificity of neuroprotection by antioxidants. J.Biomed. Sci., 2009, 16, 98.
60. Kirkland, R.A.; Franklin, J.L. Bax affects production of reactive oxygen bythe mitochondria of non-apoptotic neurons. Exp. Neurol., 2007, 204, 458-461. (Pubitemid 46330256)
61. Carriere, A.; Fernandez, Y.; Rigoulet, M.; Penicand, L.; Casteilla, L.Inhibition of preadipocyte proliferation by mitochondrial reactive oxygenspecies. FEBS Lett., 2003, 550, 163-167. (Pubitemid 37281375)
62. Lee, J.W.; Kim, W.H.; Lim, J.H.; Song, E.H.; Song, J.; Choi, K.Y.; Jung, M.H. Mitochondrial dysfunction: glucokinase downregulation lowersinteraction of glucokinase with mitochondria, resulting in apoptosis ofpancreatic-cells. Cellular Signaling, 2009, 21, 69-78.
63. Chang, C.J.; Yin, P.N.; Yang, D.M.; Wang, C.H.; Hung, W.Y.; Chi, C.W.;Wei, Y.H.; Lee, H.C. Mitochondrial dysfunction-induced amphiregulinupregulation mediates chemo-resistance and cell migration in HepG2 cells.Cell. Mol. Life Sci., 2009, 66, 1755-1765.
64. Cillero-Pastor, B.; Carames, B.; Lires-Dean, M.; Vaamonde-Garcia, C.;Blanco, F.J.; Lopez-Armada, M.J. Mitochondrial dysfunction activatescyclooxygenase 2 expression in cultured normal human chondrocytes.Arthritis Rheum., 2008, 58, 2409-2419.
65. Kadenbach, B. Intrinsic and extrinsic uncoupling of oxidativephosphorylation. Biochim. Biophys. Acta, 2003, 1604, 77-94.
66. Villani, G.; Greco, M.; Papa, S.; Attardi, G. Low reserve of cytochromeoxidase capacity in vivo in the respiratory chain of a variety of human celltypes. J. Biol. Chem., 1998, 273, 31829-31836. (Pubitemid 29177118)
67. Harris, D.A.; Das, A.M. Control of mitochondrial ATP synthesis in the heart.Biochem. J., 1991, 280, 561-573.
68. Demin, O.V.; Westerhoff, H.V.; Kholodenko, B.N. Mathematical modelingof superoxide generation with the bc1 complex of mitochondria.Biochemistry (Moscow), 1998, 63, 634-649. (Pubitemid 128588072)
69. Wittig, I.; Carrozzo, R.; Santorelli, F.M.; Schägger, H. Supercomplexes andsubcomplexes of mitochondrial oxidative phosphorylation. Biochim.Biophys. Acta - Bioenergetics, 2006, 1757, 1066-1072 (Pubitemid 44442118)
70. Allen, R.D.; Schroeder, C.C.; Fok, A.K. An investigation of mitochondrialinner membranes by rapid-freeze deep-etch techniques. J. Cell. Biol., 1989, 108, 2233-2240. (Pubitemid 19168916)
71. 0-ATP synthase and organellar internal architecture. Int. J. Biochem. CellBiol., 2009, 1, 1783-1789.
72. Paumard , P.; Vaillier, J.; Coulary, B.; Schaeffer, J.; Soubannier, V.; Mueller, D.M.; Brèthes, D.; di Rago, J.P.; Velours, J. The ATP synthase is involved ingenerating mitochondrial cristae morphology. EMBO J., 2002, 21, 221-230. (Pubitemid 34137284)
73. 0-ATP synthaserotary nanomotor in its monomeric-bacterial and dimeric-mitochondrialforms. J. Biol. Phys., 2008, 34, 197-212.
74. Bisetto, E.; Picotti, P.; Giorgio, V.; Alverdi, V.; Mavelli, I.; Lippe, G.Functional and stoichiometric analysis of subunit e in bovine heartmitochondrial F(0)F(1)ATP synthase. J. Bioenerg Biomembr., 2008, 40, 257-267.
75. 0-ATP synthase dimeric complex does not require the ATPase inhibitorprotein, Inh1. J. Biol. Chem., 2002, 277, 39289-39295. (Pubitemid 35190900)
76. Tomasetig, L.; Di Pancrazio, F.; Harris, D.A.; Mavelli, I.; Lippe, G.Dimerization of F0F1ATP synthase from bovine heart is independent fromthe binding of the inhibitor protein IF1. Biochim. Biophys. Acta -Bioenergetics, 2002, 1556, 133-141. (Pubitemid 35379671)
77. Campanella, M.; Casswell, E.; Chong, S.; Farah, Z.; Wieckowski, M.R.;Abramov, A.Y.; Tinker, A.; Duchen, M.R. Regulation of mitochondrialstructure and function by the F1Fo-ATPase inhibitor protein, IF1. CellMetab., 2008, 8, 13-25. (Pubitemid 351859227)
78. Couoh-Cardel, S.J.; Uribe-Carvajal, S.; Wilkens, S.; Garcia-Trejo, J.J.Structure of dimeric F1Fo ATP synthase. J. Biol. Chem., 2010, 285, 36447-36455.
79. Di Pancrazio, F.; Bisetto, E.; Alverdi, V.; Mavelli, I.; Esposito, G.; Lippe, G.Differential steady-state tyrosine phosphorylation of two oligomeric forms ofmitochondrial F0F1 ATP synthase: A structural proteomic analysis.Proteomics, 2006, 6, 921-926. (Pubitemid 43260216)
80. Strauss, M.; Hofhaus, G.; Schröder, R.R.; Kühlbrandt, W. Dimer ribbons ofATP synthase shape the inner mitochondrial membrane. EMBO J., 2008, 27, 1154-1160. (Pubitemid 351508145)
81. Yamada, E.W.; Huzel, N.G. The calcium binding ATPase inhibitor proteinfrom bovine heart mitochondria. J. Biol. Chem., 1988, 263, 11498-11503.
82. Yamada, E.W.; Huzel, N.G. Calcium-binding ATPase inhibitor protein ofbovine heart mitochondria. Role in ATP synthesis and effect of calcium.Biochemistry, 1989, 28, 9714-9718. (Pubitemid 20022315)
83. Zanotti, F.; Raho, G.; Gaballo, A.; Papa, S. Inhibitory and anchoringdomains in the ATPase inhibitor protein IF1 of bovine heart mitochondrialATP synthase. J. Bioenerg. & Biomembr., 2004, 36, 447-457. (Pubitemid 39491330)
84. Hong S.; Pedersen, P.L. ATP synthase and the actions of inhibitors utilizedto study its roles in human health, disease and other scientific areas.Microbiol. and Mol. Biol. Rev., 2008, 72, 590-641.
85. Paivarinne, H.; Kainulainen, H. DAPIT, a novel protein down-regulated ininsulin-sensitive tissues in streptozotocin-induced diabetes. Acta Diabetol., 2001, 38, 83-86. (Pubitemid 33035316)
86. Ohsakaya, S.; Fujikawa, M.; Hisabori, T.; Yoshida, M. Knockdown ofDAPIT (Diabetes Associated Protein in Insulin-sensitive Tissue) results inloss of ATP synthase in mitochondria. J. Biol. Chem., 2011, 286, 20292-20296.
87. Basso, E.; Petronilli, V.; Forte, M.A.; Bernardi, P. Phosphate is essential forinhibition of the mitochondrial permeability transition pore by cyclosporine and by cyclophilin D ablation., J. Biol. Chem., 2009, 283, 26307-26311.
88. Chinopoulos, C.; Konrad, C.; Kiss, G.; Metelkin, E.; Torocsik, B.; Zhang, S.F.; Starkov, A.A. Modulation of FoF1-ATP synthase activity bycyclophilin D regulates matrix adenine nucleotide levels. FEBS J., 2011, 278, 1112-1125.
89. Pozuelo R.M.; Geraghty, K.M.; Wong, B.H.C.; Wood, N.T.; Campbell, D.G.; Morrice, N.; Mackintosh, C. 14-3-3-affinity purification of over 200human phosphoproteins reveals new links to regulation of cellularmetabolism, proliferation, and trafficking. Biochem. J., 2004, 379, 395-408. (Pubitemid 38570113)
90. Galluhn, D.; Langer, T. Reversible assembly of the ATP-binding cassettetransporter Mdl1 with the F1Fo-ATP synthase in mitochondria. J. Biol. Chem., 2004, 279, 38338-38345. (Pubitemid 39295982)
91. Edmondson, R.D.; Vondriska, T.M.; Biederman, K.J.; Zhang, J.; Jones, R.C.;Zheng, Y.; Allen, D.L.; Xiu, J.X.; Cardwell, E.M.; Pisano., M.R.; Ping, P.Protein kinase C epsilon signaling complexes include metabolism- andtranscription/translation-related proteins: complimentary separationtechniques with LC/MS/MS. Mol. Cell. Proteomics, 2002, 1, 421-33.
92. Korzick, D.H.; Kostyak, J.C.; Hunter J.C.; Saupe, K.W. Local delivery ofPKC-activating peptide mimics ischemic preconditioning in aged heartsthrough GSK3β but not F1ATPase inactivation. Am. J. Physiol., 2007, 293, H2056-H2063. (Pubitemid 47605841)
93. Nguyen, T.; Ogbi, M.; Guo, D.; Johnson, J.A. Delta protein kinase Cinteracts with the d subunit of the F1Fo ATPase in neonatal cardiac myocytesexposed to hypoxia or phorbol ester: implications for F1Fo ATPaseregulation. J. Biol. Chem., 2008, 283, 29831-29840.
94. Rouslin, W. Regulation of the mitochondrial ATPase in situ in cardiacmuscle: role of the inhibitor subunit. J. Bioenerg. Biomembr., 1991, 23, 873-888.
95. Wang, Z.; White, P.S.; Ackerman, S.H. Atp11p and Atp12p are assemblyfactors for the F1-ATPase in human mitochondria. J. Biol. Chem., 2001, 276, 30773-30778. (Pubitemid 37384935)
96. Martinez, L.O.; Jacquet, S.; Esteve, J.P.; Rolland, C.; Cabezon, E.;Champagne, E.; Pineau, T.; Georgeaud, V.; Walker, J.E.; Terce, F.; Collet, X.; Perret, B.; Barbaras, R. Ectopic beta-chain of ATP synthase is anapolipoprotein A-I receptor in hepatic HDL endocytosis. Nature, 2003, 421, 75-79. (Pubitemid 36077087)
97. Alvarez-Delgado, C.; Mendoza-Rodríguez, C.A.; Picazo, O.; Cerbón, M.Different expression of α and β mitochondrial estrogen receptors in the agingrat brain: Interaction with respiratory complex V. Exper. Gerontol., 2010, 545, 580-585.
98. Massart, F.; Paolini, S.; Piscitelli, E.; Brandi, M.L.; Solaini, G. Dosedependentinhibition of mitochondrial ATP synthase by 17 beta-estradiol. Gynecol Endocrinol., 2002, 16, 373-377. (Pubitemid 35398651)
99. Zheng, J.; Ramirez, V.D. Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br. J. Pharmacol., 2000, 130, 1115-1123. (Pubitemid 30453547)
100. Kim, M.; Song, E. Iron transport by proteoliposomes containingmitochondrial F1Fo ATP synthase isolated from rat heart. Biochimie, 2010, 92, 333-342.
101. Chen, L.; Hahn, H.; Wu, G.; Chen, C-H.; Liron, T.; Schechtman, D.;Cavallaro, G.; Banci, L.; Guo, Y.; Bolli, R.; Dorn, G.W.; Mochly-Rosen, D.Opposing cardioprotective actions and parallel hypertrophic effects of PKCand PKC. Proc. Natl. Acad. Sci., USA, 2001, 98, 11114-11119. (Pubitemid 32928691)
102. Inagaki, K.; Chen, L.; Ikeno, F.; Lee, F.H.; Imahashi, K.; Bouley, D.M.;Rezaee, M.; Yock, P.G.; Murphy, E.; Mochly-Rosen, D. Inhibition of protein kinase C protects against reperfusion injury of the ischemic heart invivo. Circulation, 2003, 108, 2304-2307. (Pubitemid 37413533)
103. Murriel, C.L.; Churchill, E.; Inagaki, K.; Szweda, L.I.; Mochly-Rosen, D.Protein kinase C activation induces apoptosis in response to cardiacischemia and reperfusion damage. J. Biol. Chem., 2004, 279, 47985-47991.
104. Ikeno, F.; Inagaki, K.; Rezaee, M.; Mochly-Rosen, D. Impaired perfusionafter myocardial infarction is due to reperfusion-induced PKC-mediatedmyocardial damage. Cardiovasc. Res., 2007, 73, 699-709. (Pubitemid 46227353)
105. Yadav, V.; Yanez, N.C.; Fenton, S.C.; Denning, M.F. Loss of protein kinaseC δ gene expression in human squamous cell carcinomas: a laser capturemicrodissection study. Am. J. Pathol., 2010, 176, 1091-1096.
106. Reno, E.M.; Haughian, J.M.; Dimitrova, I.K.; Jackson, T.A.; Shoyer, K.R.;Bradford, A.P. Analysis of protein kinase C delta (PKC delta) expression inendometrial tumors. Hum. Pathol, 2008, 39, 21-29. (Pubitemid 350216168)
107. Cerda, S.R.; Mustafi, R.; Little, H.; Cohen, G.; Khare, S.; Moore, C.;Majumder, P.; Bissonnette, M. Protein kinase C delta inhibits Caco-2 cellproliferation by selective changes in cell cycle and cell death regulators.Oncogene, 2006, 25, 3123-3138. (Pubitemid 43881554)
108. Arvier, M.; Lagoutte, L.; Johnson, G.; Dumas, J.F.; Sion , B.; Grizard, G.;Malthièry, Y.; Simard, G.; Ritz, P. Adenine nucleotide translocator promotesoxidative phosphorylation and mild uncoupling in mitochondria afterdexamethasone treatment. Am. J. Physiol. Endocrino.l Metab., 2007, 293, E1320-E1324. (Pubitemid 350106600)
109. Scholz, T.D.; Balaban, R.S. Mitochondrial F1-ATPase activity of caninemyocardium: effects of hypoxia and stimulation. Am. J. Physiol. - HeartCirc Physiol., 1994, 266(6 Pt 2), H2396-H2403. (Pubitemid 24215872)
110. Kreutter, D.K.; Devlin, T.M. Inhibition of oxidative phosphorylation by anoligomer of prostaglandin B1, PGBX. Arch. Biochem. Biophys., 1983, 221, 216-226. (Pubitemid 13128236)
111. 0 ATPase -Subunit Is Regulated by Platelet-Derived Growth Factor in Mouse CorticalNeurons In Vitro. J. Neurochem., 1995, 65, 2812-2815. (Pubitemid 3002939)
112. Canto, C.; Pich, S.; Paz, J.C.; Sanchez, R.; Martinez, V.; Orpinell, M.;Palacin, M.; Zorzano, A.; Guma, A. Neuroregulins increase mitochondrialoxidative capacity and insulin sensitivity in skeletal muscle cells. Diabetes, 2007, 56, 2185-2193. (Pubitemid 47358224)
113. Abdel-Kader, R.; Hauptmann, S.; Keil, U.; Scherping, I.; Leuner, K.; Eckert, A.; Muller, W.E. Stabilization of mitochondrial function by Ginkgo Bilobaextract EGb761. Pharmacol. Res., 2007, 56, 493-502. (Pubitemid 350148165)
114. Chi, S.L.; Pizzo, V. Angiostatin is directly cytotoxic to tumor cells at lowextracellular pH: A mechanism dependent on cell surface associated ATPsynthase. Cancer Res., 2006, 66, 875-882. (Pubitemid 43165953)
115. Moser, T.L.; Stack, M.S.; Asplin, I.; Enghild, J.J.; Hojrup, P.; Everitt, L.;Hubchak, S.; Schnaper, H.W.; Pizzo, S.V. Angiostatin binds ATP synthaseon the surface of human endothelial cells. Proc. Natl. Acad. Sci., USA, 1999, 96, 2811-2816. (Pubitemid 29148800)
116. Moser, T.L.; Kenan, D.J.; Ashley, T.A.; Roy, J.A.; Goodman, M.D.; Misra, U.K.; Cheek, D.J.; Pizzo, S.V. Endothelial cell surface F1-Fo ATP synthaseis active in ATP synthesis and is inhibited by angiostatin. Proc. Natl. Acad.Sci., USA, 2001, 98, 6656-6661. (Pubitemid 32538272)
117. Kenan, D.J.; Wahl, M.L. Ectopic localization of mitochondrial ATPsynthase: A target for anti-angiogenesis intervention? J. Bioenerg. andBiomembr., 2005, 37, 461-465. (Pubitemid 43725177)
118. Kim, D.W.; Kim, K.H.; Yoo, B.C.; Hong, S.H.; Lim, Y.C.; Shin, Y.K; Park, J.G. Identification of mitochondrial F1Fo ATP synthase interacting withgalectin-3 in colon cancer cells. Cancer Sci., 2008, 99, 1884-1891.
119. Sundberg, T. B.; Ney, G. M.; Subramanian, C.; Opipari, A. W. Jr.; Glick, G.D. The immunomodulatory benzodiazepine Bz-423 inhibits B-cellproliferation by targeting c-myc protein for rapid and specific degradation.Cancer Res., 2006, 66, 1775-1782. (Pubitemid 43259963)
120. Rigoulet, M. Control processes in oxidative phosphorylation: kineticconstraints and stoichiometry. Biochim. Biophys. Acta, 1990, 1018, 185-189.
121. Jumelle-Laclau, M.; Rigoulet, M.; Averet, N.; Leverve, X.; Dubourg, L.;Carbonneau, A.; Clerc, M.; Guerin, B. Relationship between age-dependentchanges in the effect of almitrine on H+-ATPase / ATP synthase and thepattern of membrane fatty acid composition. Biochim. Biophys. Acta, 1993, 1141, 90-94. (Pubitemid 23051557)
122. Rigoulet, M.; Fraisse, L.; Ouhabi, R.; Guerin, B.; Fontaine, E.; Leverve, X.Flux-dependent increase in the stoichiometry of charge translocation bymitochondrial ATPase / ATP synthase induced by almitrine. Biochim.Biophys. Acta, 1990, 1018, 91-97
123. Rigoulet, M.; Ouhabi, R.; Leverve, X.; Putod-Paramelle, F.; Guerin, B.Almitrine, a new kind of energy-transduction inhibitor acting onmitochondrial ATP synthase. Biochim. Biophys. Acta, 1989, 975, 325-329. (Pubitemid 19196350)
124. Benzi, G. Pharmacological properties of almitrine-raubasine combination.Activity at cerebral levels. Eur. Neurol., 1998, 39 (Suppl 1), 31-38; (Pubitemid 28075315)
125. Groeneveld, A.B.J. Vascular pharmacology of acute lung injury and acuterespiratory distress syndrome. Vasc. Pharmacology, 2003, 39, 247-56;
126. Nagendran, J.; Stewart, K.; Hoskinson, M.; Archer, S.L. Ananesthesiologist's guide to hypoxic pulmonary vasoconstriction: implicationsfor managing single-lung anesthesia and atelectasis. Curr. Opin.Anesthesiol., 2006, 19, 34-43. (Pubitemid 43269474)
127. McIntyre, R.C.; Pulido, E.J.; Bensard, D.D.; Shames, B.D.; Abraham, E.Thirty years of clinical trials in acute respiratory distress syndrome. Crit.Care Med., 2000, 28, 3314-3331.
128. Prokai, L.; Stevens, S. M., Jr.; Raunlyar, N.; Nguyen, V. Rapid label-freeidentification of estrogen-induced differential protein expression in vivofrom mouse brain and uterine tissue. J. Proteome Res., 2009, 8, 3862-3867.
129. Rasbach, K.A.; Schnellmann, R.G. Isoflavones Promote Mitochondrial Biogenesis. J. Pharmacol. Exp. Therapeutics., 2008, 325, 536-543. (Pubitemid 351574800)
130. Nilsen, J.; Irwin, R.W.; Gallaher, T.K.; Brinton, R.D. Estradiol in vivoregulation of brain mitochondrial proteome. J. Neuroscience, 2007, 27, 14069-14077. (Pubitemid 351377854)
131. Hsieh, Y.C.; Yang, S.; Choudhry, M.A.; Yu, H.P.; Rue, L.W., 3rd.; Bland, K.I.; Chaudry, I.H. PGC-1 upregulat-ion via estrogen receptors: a commonmechanism of salutary effects of estrogen and flutamide on heart functionafter trauma-hemorrhage. Am. J. Physiol. Heart Circ. Physiol., 2005, 289, H2665-H2672. (Pubitemid 41698583)
132. Herzog, B.; Cardenas, J.; Hall, R.K.; Villena, J.A.; Budge, P.J.; Giguère, V.;Granner, D.K.; Kralli, A. Estrogen-related receptor is a repressor ofphosphoenolpyruvate carboxykinase gene transcription. J. Biol. Chem., 2006, 281, 99-106. (Pubitemid 43671167)
133. Writing group for the Women's Health Initiative investigators. Risks andbenefits of estrogen plus progestin in healthy postmenopausal women:principal results from The Women's Health Initiative randomized controlledtrial. JAMA, 2002, 288, 321-333.
134. Mohell, N.; Connolly, E.; Nedergaard, J. Distinction between mechanismsunderlying alpha 1- and beta-adrenergic respiratory stimulation in brown fatcells. Am. J. Physiol. Heart Circ. Res., 1987, 253(2 Pt 1), C301-C308.
135. Bains, R.; Moe, M.C.; Vinje, M.L.; Berg-Johnsen, J. Sevoflurane andpropofol depolarize mitochondria in rat and human cerebrocorticalsynaptosomes by different mechanisms. Acta Anaesthesiol. Scand., 2009, 53, 1354-1360.
136. Bains, R.; Moe, M.C.; Vinje, ML.; Berg-Johnsen, J. Isoflurane- induceddepolarization of neural mitochondria increases with age. Acta Anaesthesiol.Scand., 2009, 53, 85-92.
137. Eyles, D.; Almeras, L.; Benech, P.; Patatian, A.; Mackay-Sim, A.; McGrath, J.; Féron, F. Developmental vitamin D deficiency alters the expression ofgenes encoding mitochondrial, cytoskeletal and synaptic proteins in the adultrat brain. J. Steroid Biochem. Mol. Biol., 2007, 103, 538-545. (Pubitemid 46401360)
138. Anello, M.; Spampinato, D.; Piro, S.; Purrello, F.; Rabuazzo, A.M.Glucosamine-induced alterations of mitochondrial function in pancreatic cells: possible role of protein glycosylation. Am. J. Physiol. Endocrinol. Metab., 2004, 287, E602-E608. (Pubitemid 39237886)
139. 0ATPase by screening a Triazine library for correction of albinism. Chemistry & Biology, 2004, 11, 1251-1259. (Pubitemid 39282800)
140. Lane, R.H.; Chandorkar, A.K.; Flozak, A.S.; Simmons, R.A. Intrauterinegrowth retardation alters mitochondrial gene expression and function in fetaland juvenile rat skeletal muscle. Pediatric Res., 1998, 43, 563-570. (Pubitemid 28196445)
141. Gvozdjáková, A.; Simko, F.; Kucharská J.; Braunová, Z.; Psenek, P.;Kyselovic, J. Captopril increased mitochondrial coenzyme Q10 level, improved respiratory chain function and energy production in the leftventricle in rabbits with smoke mitochondrial cardiomyopathy. BioFactors, 1999, 10, 61-65. (Pubitemid 29500621)
142. Cambier, S.; Bénard G.; Mesmer-Dudons, N.; Gonzales, P.; Rossignol, R.;Brethes, D.; Bourdineaud, J-P. At environmental doses, dietarymethylmercury inhibits mitochondrial energy metabolism in skeletal musclesof zebra fish (Danio rerio), Int. J. Biochem. Cell Biol., 2009, 41, 791-799.
143. Younis, H.M.; Abo-El-Saad, M.M.; Abdel-Razik, R.K.; Abo-Seda, S.A.Resolving the DDT target protein in insects as a subunit of the ATPsynthetase. Biotechnol. and Appl. Biochem., 2002, 35 (Pt 1), 9-17. (Pubitemid 34171374)
144. Mildaziene, V.; Nauciene, Z.; Baniene, R.; Grigiene, J. Multiple effects of2, 2', 5, 5′-tetrachlorobiphenyl on oxidative phosphorylation in rat livermitochondria. Toxicol. Sci., 2002, 65, 220-227. (Pubitemid 34121114)
145. Shertzer, H.G.; Genter, M.B.; Shen, D.; Nebert, D.W.; Chen, Y.; Dalton, T.P.TCDD decreases ATP levels and increases reactive oxygen productionthrough changes in mitochondrial F(0)F(1)-ATP synthase and ubiquinone.Toxicol. & Appl. Pharmacol., 2006, 217:363-374. (Pubitemid 44855821)
146. 0-ATPase, early target of theradical initiator 2, 2'-azobis-(2-amidinopropane) dihydrochloride in rat livermitochondria in vitro. Biochem. J., 1996, 320:571-576.
147. Lippe, , G.; Londero, D.; Sala, F.D.; Mavelli, I. H2O2-induced damage to beefheart mitochondria F0F1 ATP synthase complex: Differential sensitivity ofthe F1 and F0 moieties. Biochem. Mol. Biol. Int., 1993, 30, 1061-1070.
148. Lippe, G.; Comelli, M.; Mazzilis, D.; Sala, D.; Mavelli, I. The inactivation ofmitochondrial F1 ATPase by H2O2 is mediated by iron ions not tightlybound in the protein. Biochem. Biophys. Res. Comm., 1991, 181, 764-770.
149. Olgun, A. Biological effects of deuteronation: ATP synthase as an example.Theor. Biol. Med. Model., 2007, 4, 9.
150. Lodeyro, A.F.; Castella, M.V.; Roveri, O.A. ATP hydrolysis-driven H+translocation is stimulated by sulfate, a strong inhibitor of mitochondrialATP synthase. J. Bioenerg. & Biomembr., 2008, 40, 269-279.
151. Hase, Y.; Tatsuno, M.; Nishi, T.; Kataoka, K.; Kabe, Y.; Yamaguchi, Y.;Ozawa, N.; Natori, M.; Handa, H.; Watanabe, H. Atrazine binds to F1FoATP synthase and inhibits mitochondrial function in sperm, Biochem. Biophys. Res. Comm., 2008, 366, 66-72. (Pubitemid 350297218)
152. Reddy, P.H. The role of mitochondria in neurodegenerative diseases:mitochondria as a therapeutic target in Alzheimer's disease. CNS Spectr., 2009, 14(8 Suppl. 7), 8-18.
153. Augereau, O.; Claverol, S.; Boudes, N.; Basurko, M-J.; Bonneu, M.;Rossignol, R.; Mazat, J-P.; Letellier, T.; Dachary-Prigent, J. Identification oftyrosine-phosphorylated proteins of the mitochondrial oxidativephosphorylation machinery. Cell. Mol. Life Sci., 2005, 62, 1478-1488. (Pubitemid 40922950)
154. Bailey, S.M.; Cunningham, C.C. Contribution of mitochondria to oxidativestress associated with alcoholic liver disease. Free Radic Biol. & Med., 2002, 32, 11-16. (Pubitemid 34045132)
155. Montgomery, R.I.; Coleman, W.B.; Eble, K.S.; Cunningham, C.C. Ethanolelicitedalterations in the oligomycin sensitivity and structural stability of themitochondrial F0F1 ATPase. J. Biol. Chem., 1987, 262, 13285-13289. (Pubitemid 18001247)
156. Venkatraman, A.; Lander, A.; Davis, A.J.; Chamlee, L.; Sanderson, T.; Kim, H.; Page, G.; Pompilius, M.; Ballinger, S.; Darley-Usmar, V.; Bailey, S.M.Modification of the mitochondrial proteome in response to the stress ofethanol-dependent hepatotoxicity. J. Biol. Chem., 2004, 279, 22092-22101. (Pubitemid 38679401)
157. Vendemiale, G.; Grattagliano, I.; Caracini, P.; Carracio, G.; Domenicali, M.;Dall'Agata, M.; Trevisani, F.; Guerrieri, F.; Bernardi, M.; Altomare, E.Mitochondrial oxidative injury and energy metabolism alteration in rat fattyliver: effect of nutritional status. Hepatology, 2001, 33, 808-815. (Pubitemid 32246628)
158. Coleman, W.B.; Cahill, A.; Ivester, P.; Cunningham, C.C. Differentialeffects of ethanol consumption on synthesis of cytoplasmic andmitochondrial encoded subunits of the ATP synthase. Alcohol Clin. Exp.Res., 1994, 18:947-950. (Pubitemid 24264118)
159. Moon, K.H.; Hood, B.L.; Kim, B.J.; Hardwick, J.P.; Conrads, T.P.; Veenstra, T.D.; Song, B.J. Inactivation of oxidized and s-nitrosylated mitochondrialproteins in alcoholic fatty liver of rats. Hepatology, 2006, 44, 1218-1230. (Pubitemid 44748372)
160. Marin-Garcia, J.; Ananthakrishnan, R.; Goldenthal, M.J. Heart mitochondriaresponse to alcohol is different than brain and liver. Alcoholism Clin. Exper.Res., 1995, 19, 1463-1466. (Pubitemid 26005694)
161. Das, A.M.; Harris, D.A. Regulation of the mitochondrial ATP synthase isdefective in rat heart during alcohol-induced cardiomyopathy. Biochim.Biophys. Acta - Molecular Basis of Disease, 1993, 1181, 295-299. (Pubitemid 23177222)
162. Li, H.; Zhang, Z.; Thompson, B.S.; Deng, X.; Ford, M.E.; Wood, P.G.; Stolz, D.B.; Eagon, P.K.; Whitcomb, D.C. Rat mitochondrial ATP synthaseATP5G3: cloning and upregulation in pancreas after chronic ethanol feeding.Physiol. Genomics, 2001, 6, 91-98. (Pubitemid 33676477)
163. Xu, Y.; Liu, P.; Li, Y. Impaired development of mitochondria plays a role inthe central nervous system defects of fetal alcohol syndrome. Birth DefectsRes. Clin. Mol. Teratol., 2005, 73, 83-91. (Pubitemid 40289532)
164. Sari, Y.; Zhang, M.; Mechref, Y. Differential expression of proteins in fetalbrains of alcohol-treated prenatally C57BL/6 mice: a proteomicinvestigation. Electrophoresis, 2010, 31, 483-496.
165. Moon, K.H.; Upreti, V.V.; Yu, L.R.; Lee, I.J.; Ye, X.; Eddington, N.D.;Veenstra, T.D.; Song, B.J. Mechanism of 3, 4- methylenedioxymethamphetamine(MDMA, ecstasy)-mediated mitochondrial dysfunction in ratliver. Proteomics, 2008, 8:3906-3918.
166. Beil, W.; Birkholz; C. Wagner, S.; Sewing, K. F. Bismuth subcitrate andomeprazole inhibit Helicobacter pylori F1-ATPase. Pharmacology, 1995, 50, 333-337.
167. Sachs, G.; Meyer-Rosberg, K.; Scott, D.R.; Melchers, K. Acid, protons, andhelicobacter pylori. Yale J. Biol. Med., 1996, 69:301-316.
168. 0) from Escherichia coli leads to resistance to aminoglycosideantibiotics. J. Bacteriol., 1989, 171, 1435-1444. (Pubitemid 19080782)
169. Lodeyro, A.F.; Calcaterra, N.B.; Roveri, O.S. Inhibition of steady-statemitochondrial ATP synthesis by bicarbon-ate, an activating ion of ATPhydrolysis. Biochim. Biophys. Acta, 2001, 1506, 236-243. (Pubitemid 34075234)
170. Wang, H.E.; Devereaux, R.S.; Yealy, D.M.; Safford, M.M.; Howard, G.National variation in United States sepsis mortality: a descriptive study. Int.J. Health Geographics, 2010, 9, 1-9.
171. Huang, L.J.; Hsu, C.; Tsai, T.N.; Wang, S.J.; Yang, R.C. Suppression ofmitochondrial ATPase inhibitor protein (IF1) in the liver of late septic rats.Biochim Biophys Acta, 2007, 1767, 888-896. (Pubitemid 47031094)
172. 0 complex by Lethal Factor is an early event in B. anthracis-induced suddencell death. Journal of Cell Death, 2009, 2, 25-39.
173. Lee, H-M.; Sugino, H.; Aoki, C.; Nishimoto, N. Underexpression ofmitochondrial-DNA encoded ATP synthesis-related genes and DNA repairgenes in systemic lupus erythematosus. BMC: Arthritis Res. & Therapy, 2011, 13, R63.
174. 0ATPase. ACS Chem. Biol., 2006, 1, 304-308.
175. Gatza, E.; Wahl, D.R.; Opipari, A.W.; Sandburg, T.B.; Reddy, P.; Lin, C.;Glick, G.D.; Ferrara, J.L. Manipulating the bioenergetics of alloreactive Tcellscauses their selective apoptosis and arrests graft-verses-host disease.Sci. Transl. Med., 2011, 3, 67ra8.
176. Grolleau, A.; Bowman, J.; Pradet-Balade, B.; Puravs, E.; Hanash, S.; Garcia-Sanz, J.A.; Beretta, L. Global and specific translational control by rapamycinin T cells uncovered by microarray and proteomics. J. Biol. Chem., 2002, 277, 22175-22184. (Pubitemid 34967182)
177. Laurent, D.; Yerby, B.; Deacon, R.; Gao, J. Diet-induced modulation ofmitochondrial activity in rat muscle. Am. J. Physiol. Endocrinol. Metab., 2007, 293, E1169-E1177. (Pubitemid 350106582)
178. Mei, J.; Wood, C.; L'abbé, M.R.; Gilani, G.S.; Cooke, G.M.; Curran, I.H.;Xiao, C.W. Biochemical, molecular, and genetic mechanisms: consumptionof soy protein isolate modulates the phosphorylation status of hepaticATPase/ATP synthase β protein and increases ATPase activity in rats.American Society for Nutrition J. Nutr., 2007, 137, 2029-2035. (Pubitemid 47367261)
179. Swartz, D.A.; Park, E.I.; Visek, W.J.; Kaput, J. The e subunit gene of murineF1Fo ATP synthase. J. Biol. Chem., 1996, 271, 20942-20948.
180. Berger K.; Sivars U.; Sorhede-Winzell M.; Johansson P.; Hellman U.; RippeC.; Erlanson-Albertsson, C. Mitochondrial ATP synthase- a possible targetprotein in the regulation of energy metabolism in vitro and in vivo. Nutr.Neuroscience, 2002, 5, 201-210. (Pubitemid 34568215)
181. Berger, K.; Winzell, M.S.; Mei, J.; Erlanson-Albertsson, C. Enterostatin andits target mechanisms during regulation of fat intake. Physiology & Behavior, 2004, 83, 623-630. (Pubitemid 40038513)
182. Lindberg, O.; de Pierre, J.; Rylander, F.; Afzelius, B.A. Studies of themitochondrial energy-transfer system of brown adipose tissue. J. Cell Biol., 1967, 34, 293-310.
183. Cannon, B.; Vogel, G. The mitochondrial ATPase of brown adipose tissue:purification and comparison with the mitochondrial ATPase from beef heart.FEBS Lett., 1977, 76, 284-289. (Pubitemid 8092425)
184. Kramarova, T.V.; Shabalina, I.G.; Andersson, U.; Westerberg, R.; Carlberg, I.; Houstek, J.; Nedergaard, J.; Cannon, B. Mitochondrial ATP synthaselevels in brown adipose tissue are governed by the c-Fo subunit P1 isoform.FASEB J., 2008, 22, 55-63.
185. Dani, D.; Shimokawa, I.; Komatsu, T.; Higami, Y.; Warnken, U.; Schokraie, E.; Schnölzer, M.; Krause, F.; Sugawa, M.D.; Dencher, N.A. Modulation ofoxidative phosphorylation machinery signifies a prime mode of anti-ageingmechanism of calorie restriction in male rat liver mitochondria.Biogerontology, 2010, 11, 321-334.
186. Bahadorani S.; Hur J.H.; Lo T.; Vu K.; Walker D.W. Perturbation ofmitochondrial complex V alters the response to dietary restriction inDrosophila, Aging Cell, 2010, 9, 100-103.
187. Copeland, J.M.; Cho, J.; Lo, T.; Hur, J.H.; Bahandoani, S.; Arabyan, T.;Rabie, J.; Soh, J.; Walker, D.W. Extension of Drosophila life span by RNAiof the mitochondrial respiratory chain. Curr. Biol., 2009, 19, 1591-1598.
188. Schwer, B.; Eckersdorff, M.; Li, Y.; Silva, J.C.; Fermin, D.; Kurtev, M.V.;Giallourakis, C.; Comb, M.J.; Alt, F.W.; Lombard, D.B. Calorie restrictionalters mitochondrial protein acetylation. Aging Cell, 2009, 8, 604-606.
189. Nicoletti, V. G.; Marino, V.M.; Cuppari, C.; Licciardello, D.; Patti, D.;Purrello, V. S.; Stella, A. M.. Effect of antioxidant diets on mitochondrialgene expression in rat brain during aging, Neurochem. Res., 2005, 30, 737-752. (Pubitemid 41413932)
190. Osanai, T.; Magota, K.; Tanaka, M.; Shimada M.; Murakami, R.; Sasaki, S.;Tomita, H.; Maeda, N.; Okumura, K. Intracellular signaling forvasoconstrictor coupling factor 6: novel function of -subunit of ATPsynthase as receptor. Hypertension, 2005, 46, 1140-1146. (Pubitemid 41533017)
191. Osanai, T.; Okada, S.; Sirato, K.; Nakano, T.; Saitoh, M.; Magota, K.;Okumura, K. Mitochondrial coupling factor 6 is present on the surface ofhuman vascular endothelial cells and is released by shear stress. Circulation, 2001, 104, 3132-3136. (Pubitemid 34014070)
192. Champagne, E.; Martinez, L.O.; Collet, X.; Barbaras, R. Ecto-F1Fo ATPsynthase / F1 ATPase: metabolic and immunological functions. Curr. Opin.Lipidol., 2006, 17, 279-284. (Pubitemid 43786062)
193. Burnstock, G. Purinergic regulation of vascular tone and remodeling.Autonomic & Autocoid Pharmacol., 2009, 29, 63-72.
194. Das, B.; Mondragon, M.O.; Sadeghian, M.; Hatcher, V.B.; Norin, A.J. Anovel ligand in lymphocyte-mediated cytotoxicity: expression of the betasubunit of H+ transporting ATP synthase on the surface of tumor cell lines.J. Exp. Med., 1994, 180, 273-281. (Pubitemid 24181076)
195. Chi, S.L.; Pizzo, S.V. Cell surface F1Fo ATP synthase: a new paradigm?Annals of Med., 2006, 38, 429-438. (Pubitemid 44484880)
196. Das, A.M.; Harris, D.A. Mitochondrial ATP synthase regulation in heart:defects in hypertension are restored after treatment with captopril.Cardioscience, 1992, 3, 227-232. (Pubitemid 23024379)
197. Brodde, O.E.; Bruck, H.; Leineweber, K. Cardiac adrenoceptors: physiological and pathophysiological relevance. J. Pharmacol. Sci., 2006, 100, 323-337.
198. Lamba, S.; Abraham, W.T. Alterations in adrenergic receptor signaling inheart failure. Heart Fail. Rev., 2000, 5, 7-16. (Pubitemid 30301507)
199. Das, A.M., Harris, D.A. Control of mitochondrial ATP synthase in heartcells: inactive to active transitions caused by beating or positive inotropicagents. Cardiovasc Res., 1990, 24, 411-417. (Pubitemid 20179593)
200. Uyemura, S.A., Curti, C. Respiration and mitochondrial ATPase in energizedmitochondria during isoproterenol-induced cell injury of myocardium. Int. J.Biochem., 1991, 23, 1143-1149.
201. Li, P.; Li, J.; Feng, X.; Li, Z.; Hou, R.; Han, C.; Zhang, Y. Gene expressionprofile of cardiomyocytes in hypertrophic heart induced by continuousnorepinephrine infusion in the rats. Cell. Mol. Life Sci., 2003, 60, 2200-2209. (Pubitemid 37357427)
202. O'Brien, T.X.; Schuyler, G.T.; Rackley, M.S.; Thompson, J.T. F1-ATPsynthase beta-subunit and cytochrome c transcriptional regulation in rightventricular hemodynamic overload and hypertrophically stimulatedcardiocytes. J. Mol. Cell. Cardiol., 1999, 31, 167-78. (Pubitemid 29078228)
203. Medeiros, D.M.; Jennings, D. Role of copper in mitochondrial biogenesis viainteraction with ATP synthase and cytochrome c oxidase. J. Bioenerg. & Biomembr., 2002, 34, 389-395. (Pubitemid 36055733)
204. Mracek, T.; Pecina, P.; Vojtiskova, A.; Kalous, M.; Sebesta, O.; Houstek, J.Two components in pathogenic mechanism of mitochondrial ATPasedeficiency: energy deprivation and ROS production. Exp. Gerontol., 2006, 41, 683-687. (Pubitemid 43870321)
205. Grover, G.J.; Malm J. Pharmacological profile of the selective mitochondrialF1Fo ATP hydrolase inhibitor BMS-199264 in myocardial ischemia.Cardiovasc.r Therapeut., 2008, 26, 287-296.
206. Imahashi, K.; Schneider, M.D.; Steenbergen, C.; Murphy, E. Transgenicexpression of Bcl-2 modulates energy metabolism, prevents cytosolicacidification during ischemia, and reduces ischemia / reperfusion injury.Circ. Res., 2004, 95, 734-741. (Pubitemid 39331934)
207. Neubauer, S.; Hu, K.; Horn, M.; Remkes, H.; Hoffmann, K. D.; Schmidt, C.;Schmidt, T. J.; Schnackerz, K.; Ertl, G. Functional and energeticconsequences of chronic myocardial creatine depletion by Guanidinopropionate in perfused hearts and in intact rats. J. Mol. Cell.Cardiol., 1999, 31, 1845-1855. (Pubitemid 29458702)
208. Ingwall, J.S.; Weiss, R.G. Is the failing heart energy starved? On usingchemical energy to support cardiac function. Circ. Res., 2004, 95:135-145. (Pubitemid 38988679)
209. Lloyd-Jones D.; Adams, R.J.; Brown, T.M.; Carnethon, M.; Dai, S.; DeSimone, G.; Ferguson, T.B.; Ford, E.; Furie, K.; Gillespie, C.; Go, A.;Greenlund, K.; Haase, N.; Hailpern, S.; Ho, P.M.; Howard, V.; Kissela, B.;Kittner, S.; Lackland, D.; Lisabeth, L.; Marelli, A.; McDermott, M.M.;Meigs, J.; Mozaffarian, D.; Mussolino, M.; Nichol, G.; Roger, V.L.;Rosamond, W.; Sacco, R.; Sorlie, P.; Thom, T.; Wasserthiel-Smoller, S.;Wong, N.D.; Wylie-Rosett, J.; Heart disease and stroke statistics-2010update: a report from the American Heart Association. Circulation, 2010, 121, e46-e215.
210. Rouslin, W.; Broge, C.W.; Grupp, I.L. ATP depletion and mitochondrialfunctional loss during ischemia in slow and fast heart-rate hearts. Am. J.Physiol. Heart Circ. Physiol., 1990, 259, H1759-H1766.
211. St-Pierre, J.; Brand, M.D.; Boutilier, G. Mitochondria as ATPconsumers:cellular treason in anoxia Proc. Natl. Acad. Sci. USA, 2000, 97, 8670-8674.
212. Murry, C.E.; Jennings, R.B.; Reimer, K.A. Preconditioning with ischemia: adelay of lethal cell injury in ischemic myocardium. Circulation, 1986, 74, 1124-1136. (Pubitemid 17174962)
213. Cohen, M.V.; Baines, C.P.; Downey, J.M. Ischemic preconditioning: fromadenosine receptor to KATP channel. Annu. Rev. Physiol., 2000, 62, 79-109. (Pubitemid 30618257)
214. Riess, M.L.; Stowe, D.F.; Warltier, D.C. Cardiac pharmacologicalpreconditioning with volatile anesthetics: from bench to bedside. Am. J.Physiol. (Heart Circ. Physiol)., 2004, 286, H1603-H1607. (Pubitemid 38525444)
215. Arrell, D.K.; Elliott, S.T.; Kane, L.A.; Guo, Y.; Ko, Y.H.; Pedersen, P.L.;Robinson, J.; Murata, M.; Murphy, A.M.; Marbán, E.; Van Eyk, J.E.Proteomic analysis of pharmacological preconditioning novel protein targetsconverge to mitochondrial metabolism pathways. Circ. Res., 2006, 99, 706-714. (Pubitemid 44498304)
216. Kane, L.A.; Youngman, M.J.; Jensen, R.E.; Van Eyk, J.E. Phosphorylationof the F1Fo ATP synthase - subunit functional and structural consequencesassessed in a model system. Circ. Res., 2010, 106, 504-513.
217. Bosetti, F.; Yu, G.; Zucchi, R.; Ronca-Testoni, S.; Solaini, G. Myocardialischemic preconditioning and mitochondrial F1Fo ATPase activity. Mol.Cell. Biochem., 2000, 215, 31-38. (Pubitemid 32094940)
218. Ylitalo, K.; Ala-Rami, A.; Vuorinen, K.; Peuhkurinen, K.; Lepojarvi, M.;Kaukoranta, P.; Kiviluoma, K.; Hassinen, I. Reversible ischemic inhibitionof F1Fo-ATPase in rat and human myocardium. Biochim. Biophys. Acta, 2001, 1504, 329-339. (Pubitemid 32201904)
219. Contessa, S.; Metelli, G.; Mavelli, I.; Lippe, G. Diazoxide affects the IF1inhibitor protein binding to F1 sector of beef heart FoF1 ATP synthase.Biochem. Pharmacol., 2004, 67, 1843-1851. (Pubitemid 38591373)
220. Comelli, M.; Metelli, G.; Mavelli, I. Downmodulation of FoF1 ATP synthaseby diazoxide in cardiac myoblasts: a dual effect of the drug. Am. J. Physiol., 2007, 292, H820-H829.
221. Belisle, E.; Kowaltowski, A. J. Opening of mitochondrial K+ channelsincreases ischemic ATP levels by preventing hydrolysis. J. Bioenerg.Biomembr., 2002, 34, 285-298.
222. Ardehali, H.; Chen, Z.; Young, K.; Mejia-Alvarez, R.; Marban, E.Multiprotein complex containing succinate dehydrogenase confersmitochondrial ATP-sensitive K+ Channel activity. Proc. Natl. Acad. Sci., USA, 2004, 101, 11880-11885. (Pubitemid 39095388)
223. Ala-Rami, A.; Ylitalo. K.V.; Hassinen, I.E. Ischaemic preconditioning and amitochondrial KATP channel opener both produce cardioprotectionaccompanied by F1Fo ATPase inhibition in early ischaemia. Basic Res.Cardiol., 2003, 98, 250-258. (Pubitemid 36874024)
224. Hanley, P.J.; Mickel, M.; Loffler, M.; Brandt, U.; Daut, J. KATP channelindependenttargets of diazoxide and 5-hydroxydecanoate in the heart. J.Physiol., 2002, 542, 735-741. (Pubitemid 34947269)
225. Schafer, C.; Wegener, C.; Portenhauser, R.; Bojanovski, D. Diazoxide, aninhibitor of succinate oxidation. Biochem. Pharmacol., 1969, 18, 2678-2681.
226. Halestrap, A. P.; Clarke, S.J.; Khaliulin, I. The role of motochondria inprotection of the heart by preconditioning. Biochim. Biophys. Acta, 2007, 1767, 1007-1031. (Pubitemid 47101788)
227. Inagaki, K.; Churchill, E.; Mochly-Rosen, D. Epsilon protein kinase C as apotential therapeutic target for the ischemic heart. Cardiovasc. Res., 2006, 70, 222-230.
228. DELTA MI Investigators. Intracoronary KAI-9803 as an adjunct to primarypercutaneous coronary intervention for acute ST-segment elevationmyocardial infarction. Circulation, 2008, 117, 886-896.
229. Schwarze, S.R.; Ho, A.; Vocero-Akbani, A.; Dowdy, S.F. In vivo proteintransduction: delivery of a biologically active protein into the mouse.Science, 1999, 285, 1569-1572. (Pubitemid 29420581)
230. Lemire, B.D.; Fankhauser, C.; Baker, A.; Schatz, G. The mitochondrialtargeting function of randomly generated peptide sequences correlates withpredicted helical amphiphilicity. J. Biol. Chem., 1989, 264, 20206-20215. (Pubitemid 20009197)
231. Scheuermann-Freestone, M.; Madsen, P.L.; Manners, D.; Blamire, A.M.;Buckingham, R.E.; Styles, P.; Radda, G.K.; Neubauer, S.; Clarke, K.Abnormal cardiac and skeletal muscle energy metabolism in patients withtype 2 diabetes. Circulation, 2003, 107, 3040-3046. (Pubitemid 36758977)
232. Stump, C.S.; Short, K.R.; Bigelow, M.L.; Schimke, J.M.; Nair, K.S. Effect ofinsulin on human skeletal muscle mitochondrial ATP production, proteinsynthesis, and mRNA transcripts. Proc. Natl. Acad. Sci., USA., 2003, 100, 7996-8001. (Pubitemid 36760083)
233. Rutanen, J.; Yaluri, N.; Modi, S.; Pihlajamaki, J.; Vanttinen, M.; Itkonen, P.;Kainulainen, S.; Yamamoto, H.; Lagouge, M.; Sinclair, D. A.; Elliott, P.;Westphal, C.; Auwerx, J.; Laakso, M. SIRT1 mRNA expression may beassociated with energy expenditure and insulin sensitivity. Diabetes, 2010, 59, 829-835.
234. Hojlund, K.; Wrzesinski, K.; Larsen, P.M.; Fey, S.J.; Roepstorff, P.;Handberg, A.; Dela, F.; Vinten, J.; McCormack, J.G.; Reynet, C.; Beck-Nielsen, H. Proteome analysis reveals phosphorylation of ATP synthase subunit in human skeletal muscle and proteins with potential roles in type 2diabetes. J. Biol. Chem., 2003, 278, 10436-10442. (Pubitemid 36800309)
235. Yang, J-Y.; Yeh, H-Y.; Lin, K.; Wang, P.H. Insulin stimulates Akttranslocation to mitochondria: implications on dysregulation ofmitochondrial oxidative phosphorylation in diabetic myocardium. J. Mol.Cell. Cardiol., 2009, 46, 919-926.
236. Bodina, S.; Sena, S.; Theobald, H.; Sheng, X.; Wright, J.J.; Hu, X.X.; Aziz, S.; Johnson, J.I.; Bugger, H.; Zaha, V.G.; Abel, E.D. Mitochondrialenergetics in the heart in obesity related diabetes: direct evidence forincreased uncoupled respiration and activation of uncoupling proteins.Diabetes, 2007, 56, 2457-2466. (Pubitemid 47523253)
237. Folli, F.; Guzzi, V.; Perego, L.; Coletta, D.K.; Finzi, G.; Placidi, C.; LaRosa, S.; Capella, C.; Socci, C.; Lauro, D.; Tripathy, D.; Jenkinson, C.;Paroni, R.; Orsenigo, E.; Cighetti, G.; Gregorini, L.; Staudacher, C.; Secchi, A.; Bachi, A.; Brownlee, M.; Fiorina, P. Proteomics reveals novel oxidativeand glycolytic mechanisms in type 1 diabetic patients' skin which arenormalized by kidney-pancreas transplantation. PLoS One, 2010, 29, 5, e9923.
238. Bugger, H.; Chen, D.; Riehle, C.; Soto, J.; Theobald, H. A.; Hu, X. X.;Ganesan, B.; Weimer, B. C.; Abel, E. D.. Tissue-specific remodeling of themitochondrial proteome in type 1 diabetic Akita mice. Diabetes, 2009, 58, 1986-1997.
239. Kim, M.J.; Berdanier, C.D. Nutrient-gene interactions determinemitochondrial function: effect of dietary fat. FASEB J., 1998, 12, 243-248. (Pubitemid 28080194)
240. Turko, I.V.; Murad , F. Quantitative protein profiling in heart mitochondriafrom diabetic rats. J. Biol. Chem., 2003, 278, 35844-35849. (Pubitemid 37102363)
241. Hojlund, K.; Yi, Z.; Lefort, N.; Langlais, P.; Bowen, B.; Levin, K.; Beck-Nielsen, H.; Mandarino, L.J. Human ATP synthase beta is phosphorylated atmultiple sites and shows abnormal phosphorylation at specific sites ininsulin-resistant muscle. Diabetologia, 2010, 53, 541-551.
242. Saleh, M.C.; Fatehi-Hassanabad, Z.; Wang, R.; Nino-Fong, R.; Wadowska, D.W.; Wright, G.M.; Harper, M.E.; Chan, C.B. Mutated ATP synthaseinduces oxidative stress and impaired insulin secretion in beta-cells of femaleBHE/cdb rats. Diabetes Metab. Res. Rev., 2008, 24, 392-403.
243. Warburg, O. On Respiratory impairment in cancer cells. Science, 1956, 124, 269-270.
244. Sánchez-Cenizo, L.; Formentini, L.; Aldea, M.; Ortega, A.D.; García-Huerta, P.; Sánchez-Aragó, M.; Cuezva, J.M. Up-regulation of the ATPase inhibitoryfactor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumorsmediates the metabolic shift of cancer cells to a Warburg phenotype. J. Biol. Chem., 2010, 285, 25308-25313.
245. Shen, L.; Zhi, L.; Hu, W.; Wu, M.X. IEX-1 targets mitochondrial F1Fo-ATPase inhibitor for degradation. Cell Death Differ., 2009, 16, 603-612.
246. Chang, C.J.; Yin, P.H.; Yang, D.M.; Wang, C.H.; Hung, W.Y.; Chi, C.W.;Wei, Y.H.; Lee, H.C. Mitochondrial dysfunction-induced amphiregulinupregulation mediates chemo-resistance and cell migration in HepG2 cells.Cell. Mol. Life Sci., 2009, 66, 1755-1765.
247. Salomon, A.R.; Voehringer, D.W.; Herzenberg L.A.; Khosla C. Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase. Chemistry & Biology, 2001, .8, 71-80. (Pubitemid 32165813)
248. Sundberg, T. B.; Ney, G. M.; Subramanian, C.; Opipari, A. W. Jr.; Glick, G.D. The immunomodulatory benzodiazepine Bz-423 inhibits B-cellproliferation by targeting c-myc protein for rapid and specific degradation.Cancer Res., 2006, 66, 1775-1782. (Pubitemid 43259963)
249. Singh, S.; Khar, A. Differential gene expression during apoptosis induced bya serum factor: role of mitochondrial F0-F1 ATP synthase complex.Apoptosis, 2005, 10, 1468-1482.
250. Yang, D.; Wang, M.T.; Tang, Y.; Chen, Y.; Jiang, H.; Jones, T.T.; Rao, K.;Brewer, G.J.; Singh, K.K.; Nie, D. Impairment of mitochondrial respirationin mouse fibroblasts by oncogenic H-RASQ6IL. Cancer Biol. Therapy, 2010, 9, 122-133.
251. Hao, W.; Chang, B.C.; Tsao, C.; Xu, J. Oligomycin-induced bioenergeticadaptation in cancer cells with heterogeneous bioenergetics organizations. J. Biol. Chem., 2010, 285, 12647-12654.
252. Gong, Y.; Agani, F.H. Oligomycin inhibits HIF-1 expression in hypoxictumor cells. Am J Physiol Cell Physiol., 2005, 288, C1023-C1029. (Pubitemid 40559378)
253. Riby, J.E.; Firestone, G.L.; Bjeldanes. L.F. 3, 3'-Diindolylmethane reduceslevels of HIF-1 and HIF-1 activity in hypoxic cultured human cancer cells.Biochem. Pharmacol., 2008, 75, 1858-1867.
254. Seo, H.S.; Journé, F.; Larsimont, D.; Sotiriou, C.; Leclercq, G. Decrease ofestrogen receptor expression and associated ERE-dependent transcription inMCF-7 breast cancer cells after oligomycin treatment. Steroids, 2003, 68, 257-269. (Pubitemid 36298789)
255. Shchepina, L.A.; Pletjushkina, O.Y.; Avetisyan, A.V.; Bakeeva, L.E.;Fetisova, E.K.; Izyumov, D.S.; Saprunova, V.B.; Vyssokikh, M.Y.;Chernyak, B.V.; Skulachev, V.P. Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis. Oncogene, 2002, 21, 8149-8157. (Pubitemid 35454417)
256. Chen, I.; Hsieh, T.; Thomas, T.; Safe, S. Identification of estrogen-inducedgenes downregulated by AhR agonists in MCF-7 breast cancer cells usingsuppression subtractive hybridization. Gene, 2001, 262, 207-214. (Pubitemid 32155351)
257. Chen, L.S.; Nowak, B.J.; Ayres, M.L.; Krett, N.L; Rosen, S.T.; Zhang, S.;Gandhi, V. Inhibition of ATP synthase by chlorinated adenosine analogue.Biochem. Pharmacol., 2009, 78, 583-591.
258. Huang, T.C.; Chang, H.Y.; Hsu, C.H.; Kuo, W.H.; Chang, K.J.; Juan, H.F.Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertinB. J. Proteome Res., 2008, 7, 1433-1444.
259. Tan, D.J.; Chang, J.; Liu, L.L.; Bai, R.K.; Wang, Y.F.; Yeh, K.T.; Wong, L.J. Significance of somatic mutations and content alteration ofmitochondrial DNA in esophageal cancer. BMC Cancer, 2006, 6, 93.
260. 0-ATP synthase inhuman colon cancer cells with induced 5-fluorouracil resistance. CancerRes., 2005, 65, 3162-3170. (Pubitemid 40524597)
261. Johnson, K.M.; Swenson, L.; Opipari, A.W. Jr.; Reuter, R.; Zarrabi, N.;Fierke, C.A.; Borsch, M.; Glick, G.D. Mechanistic basis for differentialinhibition of F1Fo ATPase by aurovertin. Biopolymers, 2009, 91, 830-840.
262. Mao, L.; Zabel, C.; Wacker, M.A.; Nebrich, G.; Sagi, D.; Schrade, P.;Bachmann, S.; Kowald, A..; Klose, J. Estimation of the mtDNA mutationrate in aging mice by proteome analysis and mathematical modeling. Exp.Gerontol., 2006, 41, 11-24. (Pubitemid 43031363)
263. Puche J.E.; Garcia-Fernandez, M.; Muntane, J.; Rioja, J.; Gonzalez-Baron, S.; Cortazar, I.C. Low doses of insulin-like growth factor-I inducemitochondrial protection in aging rats. Endocrinology, 2008, 149, 2620-2627. (Pubitemid 351574499)
264. Dencher, N.A.; Frenzel, M.; Reifschneider, N.H.; Sugawa, M.; Krause, K.Proteome alterations in rat mitochondria caused by ageing. Ann. NY Acad.Sci., 2007, 1100, 291-298. (Pubitemid 47092664)
265. Sultana, R.; Poon, H.F.; Cai, J.; Pierce, W.M.; Merchant, M.; Klein, J.B.;Markesbery, W.R.; Butterfield, D.A. Identification of nitrated proteins inAlzheimer's disease brain using a redox proteomics approach. Neurobiol.Dis., 2006, 22, 76-87.
266. Lam, P.Y.; Yin, F.; Hamilton, R.T.; Boveris, A.; Cadenas, E. Elevatedneuronal nitric oxide synthase expression during ageing and mitochondrialenergy production. Free Radical Res., 2009, 43, 431-439.
267. Prokai, L.; Yan, L-J.; Vera-Serrano, J. L.; Stevens, S. M., Jr.; Forster, M. J.Mass spectrometry-based identification of mitochondrial proteins susceptibleto age-related oxidative carbonylation in the rat brain. J. Mass Spectrom., 2007, 42, 1583-1589.
268. Pamplona, R.; Dalfó, E.; Ayala, V.; Bellmunt, M.J.; Prat, J.; Ferrer, I.;Portero-Otín, M. Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease andidentification of lipoxidation targets J. Biol. Chem., 2005, 280, 21522-21530. (Pubitemid 40805718)
269. Szweda, P. A.; Camouse, M.; Lundberg, K. C.; Oberley, T. D.; Szweda, L. I.Aging, lipofuscin formation, and free radical-mediated inhibition of cellularproteolytic systems. Ageing Res. Rev., 2003, 2, 383-405. (Pubitemid 37159400)
270. Conley, K.E.; Marcinek, D.J.; Villarin, J. Mitochondrial dysfunction and age.Curr. Opin. Clin. Nutr. & Metabolic Care, 2007, 10, 688-692. (Pubitemid 350293768)
271. Preston, C.C.; Oberlin, A.S.; Holmuhamedov, E.L.; Gupta, A.; Sagar, S.;Syed, R.H.; Siddiqui, S.A.; Raghavakaimal, S.; Terzic, A..; Jahangir, A.Aging-induced alterations in gene transcripts and functional activity ofmitochondrial oxidative phosphorylation complexes in the heart. Mech.Ageing Dev., 2008, 129, 304-312.
272. Chakravarti, B.; Oseguera, M.; Dalal, N.; Fathy, P.; Mallik, B.; Raval, A.;Chakravarti, D.N. Proteomic profiling of aging in the mouse heart: Alteredexpression of mitochondrial proteins. Arch. Biochem. Biophys., 2008, 474, 22-31.
273. Chung, W.G.; Miranda, C.L.; Maier, C.S. Detection of carbonyl- modifiedproteins in interfibrillar rat mitochondria using N- aminooxymethylcarbonylhydrazino-D-biotin as an aldehyde / keto-reactive probe incombination with Western blot analysis and tandem mass spectrometry. Electrophoresis, 2008, 29, 1317-1324. (Pubitemid 351461085)
274. Choksi, K.B.;Papaconstantinou, J. Age-related alterations in oxidativelydamaged proteins of mouse heart mitochondrial electron transport chaincomplexes. Free Radic. Biol. Med., 2008, 44, 1795-1805.
275. Choksi, K.B.; Nuss, J.E.; Boylston, W.H.; Rabek, J.P.; Papaconstantinou, J.Age-related increases in oxidatively damaged proteins of mouse kidneymitochondrial electron transport chain complexes. Free Radic. Biol. Med., 2007, 43, 1423-1438. (Pubitemid 47532365)
276. Haynes, V.; Traaseth, N.J.; Elfering, S.; Fujisawa, Y.; Giulivi, C. Nitration ofspecific tyrosines in FoF1 ATP synthase and activity loss in aging. Am. J.Physiol. Endocrinol. Metab., 2010, 298, E978-E987.
277. Capitanio, D.; Vasso, M.; Fania, C.; Moriggi, M.; Viganò, A.; Procacci, P.;Magnaghi, V.; Gelfi, C. Comparative proteomic profile of rat sciatic nerveand gastrocnemius muscle tissues in ageing by 2-D DIGE. Proteomics, 2009, 9, 2004-2020.
278. Mansouri, A.; Muller, F.L.; Liu, Y.; Ng, R.; Faulkner, J.; Hamilton, M.;Richardson, A.; Huang, T.T.; Epstein, C.J.; Van Remmen, H. Alterations inmitochondrial function, hydrogen peroxide release and oxidative damage inmouse hind-limb skeletal muscle during aging. Mech. Ageing Dev., 2006, 127, 298-306. (Pubitemid 43214503)
279. Feng, J.; Xie, H.; Meany, D.L.; Thompson, L.V.; Arriaga, E.A.; Griffin, T.J.Quantitative proteomic profiling of muscle type and age-dependent proteincarbonylation in rat skeletal muscle mitochondria. J. Gerontol. A Biol. Sci.Med. Sci., 2009, 63, 1137-1152. (Pubitemid 352772034)
280. Trifunovic, A. Mitochondrial DNA and ageing. Biochim. Biophys. Acta, 2006, 1757, 611-617. (Pubitemid 43993842)
281. Trifunic, A.; Hansson, A.; Wredenberg, A.; Rovio, A..T.; Dufour, E.;Khvorostov, I.; Spelbrink, J.N.; Wibom, R.; Jacobs, H.T.; Larsson, N-G.Somatic mtDNA mutations cause aging phenotypes without affectingreactive oxygen species production. Proc. Natl. Acad. Sci., USA, 2005, 102, 17993-17998. (Pubitemid 41798490)
282. Edgar, D.; Trifunic, A. The mtDNA mutator mouse: dissecting mitochondrialinvolvement in aging. Aging, 2009, 1, 1028-1032.
283. Hiona, H.; Sanz, A.; Kujoth, G.C.; Pamplona, R.; Seo, A.Y.; Hofer, T.;Someya, S.; Miyakawa, T.; Nakayama, C.; Samhan-Arias, A.K.; Servais, S.;Barger, J.L.; Portero-Otin, M.; Tanokura, M.; Prolla, T.A.; Leewenburgh, C.Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis, and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice. PLoSONE, 2010, 5, Article ID e11428.
284. Stockl, P.; Hutter, E.; Zwerschke, W.; Jansen-Durr, P. Sustained inhibition ofoxidative phosphorylation impairs cell proliferation and induces prematuresenescence in human fibroblasts. Exp. Gerontol., 2006, 41, 674-682. (Pubitemid 43866356)
285. Yap, L.P.; Garcia, J.V.; Han, D.; Cadenas, E. The energy-redox axis in agingand age-related neurodegeneration. Adv. Drug Deliv. Rev., 2009, 61, 1283-1298.
286. Meany, D. L.; Xie, H.; Thompson, L. V.; Arriaga, E. A.; Griffin, T. J.Identification of carbonylated proteins from enriched rat skeletal musclemitochondria using affinity chromatography-stable isotope labeling andtandem mass spectrometry. Proteomics, 2007, 7, 1150-1163. (Pubitemid 46649164)
287. Baracca, A.; Sgarbi, G.; Mattiazzi, M.; Casalena, G.; Pagnotta, E.; Valentino, M.L.; Moggio, M.; Lenaz, G.; Carelli, V.; Solaini, G. Biochemicalphenotypes associated with the mitochondrial ATP6 gene mutations atnt8993. Biochim. Biophys. Acta., 2007, 1767:913-919. (Pubitemid 47031105)
288. Wallace, D.C. A mitochondrial paradigm of metabolic and degenerativediseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev.Genet., 2005, 39, 359-407. (Pubitemid 43011120)
289. Mattiazzi, M.; Vijayvergiya, C.; Gajewski, C.D.; DeVivo, D.C.; Lenaz, G.;Wiedmann, M.; Manfredi, G. The mtDNA T8993G (NARP) mutation resultsin an impairment of oxidative phosphorylation that can be improved byantioxidants. Hum. Mol. Genet., 2004, 13, 869-879. (Pubitemid 38515215)
290. 0 F1F0-ATP synthasewithout preventing enzyme assembly and oligomerization. J. Biol. Chem., 2007, 282, 1051-1058. (Pubitemid 47076544)
291. Jesina P.; Tesarova M.; Fornuskova D.; Vojtiskova A.; Pecina P.; KaplanovaV.; Hansikova H.; Zeman J.; Houstek, J. Diminished synthesis of subunit a(ATP6) and altered function of ATP synthase and cytochrome c oxidase dueto the mtDNA 2 bp microdeletion of TA at positions 9205 and 9206.Biochem. J., 2004, 383, 561-571. (Pubitemid 39546127)
292. Sgarbi, G.; Casalena, G.A.; Baracca, A.; Lenaz, G.; DiMauro, S.; Solaini, G.Human NARP mitochondrial mutation metabolism corrected with alphaketoglutarate/aspartate: a potential new therapy. Arch. Neurol., 2009, 66, 951-957.
293. McKenzie, M.; Liolitsa, D.; Akinshina, N.; Campanella, M.; Sisodiya, S.;Hargreaves, I.; Nirmalananthan, N.; Sweeney, M.G.; Abou-Sleiman, P.M.;Wood, N.W.; Hanna, M.G.; Duchen, M.R. Mitochondrial ND5 genevariation associated with encephalomyopathy and mitochondrial ATPconsumption. J. Biol. Chem., 2007, 282, 36845-36852.
294. Bonda, D.J.; Wang, X.; Perry, G.; Smith, M.A.; Zhu, X. Mitochondrialdynamics in Alzheimer's disease: opportunities for future treatmentstrategies. Drugs & Aging, 2010, 27, 181-192.
295. Fu, Y.J.; Xiong, S.; Lovell, M.A.; Lynn, B.C. Quantitative proteomicanalysis of mitochondria in aging PS-1 transgenic mice. Cell. Mol.Neurobiol., 2009, 29, 649-664.
296. Arthur, C. R.; Morton, S. L.; Dunham, L. D.; Keeney, P. M.; Bennett, J. P., Jr. Parkinson's disease brain mitochondria have impaired respirasomeassembly, age-related increases in distribution of oxidative damage tomtDNA and no differences in heteroplasmic mtDNA mutation abundance.Mol. Neurodegen., 2009, 4, 37.
297. Valenti, D.; Tullo, A.; Caratozzolo, M.F.; Merafina, R.S.; Scartezzini, P.;Marra, E.; Vacca, R.A. Impairment of F1Fo ATPase, adenine nucleotidetranslocator, and adenylate kinase causes mitochondrial energy deficit inhuman skin fibroblasts with chromosome 21 trisomy. Biochem. J., 2010, 431, 299-310.
298. Gotow, T.; Shibata, M.; Kanamori, S.; Tokuno, O.; Ohsawa, Y.; Sato, N.;Isahara, K.; Yayoi, Y.; Watanabe, T.; Leterrier, J.F.; Linden, M.; Kominami, E.; Uchiyama, Y. Selective localization of Bcl-2 to the inner mitochondrialand smooth endoplasmic reticulum membranes in mammalian cells. CellDeath and Differentiation, 2000, 7, 666-674.file://localhost/info/pmid:10889511 (Pubitemid 30456172)
299. Souza, M.E.J.; Polizello, A.C.M.; Uyemura, S.A.; Castro-e-Silva, O., Jr.;Curti, C. Effect of fluoxetine on rat liver mitochondria. Biochem.Pharmacol., 1994, 48, 535-541. (Pubitemid 24257016)
300. Dabbeni-Sala, F.; Palatini, P. Mechanism of local anesthetic effect.Involvement of F0 in the inhibition of mitochondrial ATP synthase byphenothiazines. Biochim. Biophys. Acta - Bioenergetics, 1990, 1015, 248-252.
301. Cho, J.H.; Balasubramanyam, M.; Chernaya, G.; Gardner, J.P.; Aviv, A.;Reeves, J.P.; Dargis, P.G.; Christian, E.P. Oligomycin inhibits store-operatedchannels by a mechanism independent of its effects on mitochondrial ATP.Biochem. J., 1997, 324, 971-980. (Pubitemid 27285559)
302. Syroeshkin, A.V.; Vasilyeva, E.A.; Vinogradov, A.D. ATP synthesiscatalyzed by the mitochondrial F1-F0 ATP synthase is not a reversal of itsATPase activity. FEBS Lett., 1995, 366, 29-32.
303. Schagger, H.; Pfeiffer, K. Supercomplexes in the respiratory chains of yeastand mammalian mitochondria. EMBO J., 2000, 19:1777-1783. (Pubitemid 30204389)